Table of Content

1. Service Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Minimally Invasive Biopsy Techniques Market
5. Voice of Customer
6. Clinical Trial Analysis
7. Patent Analysis
8. Global Minimally Invasive Biopsy Techniques Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
8.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.})
8.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.})
8.2.4. By Application (Clinical v/s Therapeutic)
8.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
8.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
8.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centers)
8.2.6. By Company (2021)
8.2.7. By Region
8.3. Market Map
9. North America Minimally Invasive Biopsy Techniques Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
9.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
9.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
9.2.4. By Application (Clinical v/s Therapeutic)
9.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
9.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
9.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centers)
9.2.6. By Country
9.3. North America: Country Analysis
9.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Offered
9.3.1.2.2. By Technique
9.3.1.2.3. By Circulating Biomarker
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Offered
9.3.2.2.2. By Technique
9.3.2.2.3. By Circulating Biomarker
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Offered
9.3.3.2.2. By Technique
9.3.3.2.3. By Circulating Biomarker
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Europe Minimally Invasive Biopsy Techniques Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
10.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
10.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
10.2.4. By Application (Clinical v/s Therapeutic)
10.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
10.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
10.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
10.2.6. By Country
10.3. Europe: Country Analysis
10.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Offered
10.3.1.2.2. By Technique
10.3.1.2.3. By Circulating Biomarker
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Offered
10.3.2.2.2. By Technique
10.3.2.2.3. By Circulating Biomarker
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Offered
10.3.3.2.2. By Technique
10.3.3.2.3. By Circulating Biomarker
10.3.3.2.4. By Application
10.3.3.2.5. By End User
10.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product Offered
10.3.4.2.2. By Technique
10.3.4.2.3. By Circulating Biomarker
10.3.4.2.4. By Application
10.3.4.2.5. By End User
10.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product Offered
10.3.5.2.2. By Technique
10.3.5.2.3. By Circulating Biomarker
10.3.5.2.4. By Application
10.3.5.2.5. By End User
10.3.6. Poland Minimally Invasive Biopsy Techniques Market Outlook
10.3.6.1. Market Size & Forecast
10.3.6.1.1. By Value
10.3.6.2. Market Share & Forecast
10.3.6.2.1. By Product Offered
10.3.6.2.2. By Technique
10.3.6.2.3. By Circulating Biomarker
10.3.6.2.4. By Application
10.3.6.2.5. By End User
11. Asia-Pacific Minimally Invasive Biopsy Techniques Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
11.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
11.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
11.2.4. By Application (Clinical v/s Therapeutic)
11.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
11.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
11.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
11.2.6. By Country
11.3. Asia-Pacific: Country Analysis
11.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Offered
11.3.1.2.2. By Technique
11.3.1.2.3. By Circulating Biomarker
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Offered
11.3.2.2.2. By Technique
11.3.2.2.3. By Circulating Biomarker
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Offered
11.3.3.2.2. By Technique
11.3.3.2.3. By Circulating Biomarker
11.3.3.2.4. By Application
11.3.3.2.5. By End User
11.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product Offered
11.3.4.2.2. By Technique
11.3.4.2.3. By Circulating Biomarker
11.3.4.2.4. By Application
11.3.4.2.5. By End User
11.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Product Offered
11.3.5.2.2. By Technique
11.3.5.2.3. By Circulating Biomarker
11.3.5.2.4. By Application
11.3.5.2.5. By End User
11.3.6. Thailand Minimally Invasive Biopsy Techniques Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Product Offered
11.3.6.2.2. By Technique
11.3.6.2.3. By Circulating Biomarker
11.3.6.2.4. By Application
11.3.6.2.5. By End User
11.3.7. Vietnam Minimally Invasive Biopsy Techniques Market Outlook
11.3.7.1. Market Size & Forecast
11.3.7.1.1. By Value
11.3.7.2. Market Share & Forecast
11.3.7.2.1. By Product Offered
11.3.7.2.2. By Technique
11.3.7.2.3. By Circulating Biomarker
11.3.7.2.4. By Application
11.3.7.2.5. By End User
11.3.8. Malaysia Minimally Invasive Biopsy Techniques Market Outlook
11.3.8.1. Market Size & Forecast
11.3.8.1.1. By Value
11.3.8.2. Market Share & Forecast
11.3.8.2.1. By Product Offered
11.3.8.2.2. By Technique
11.3.8.2.3. By Circulating Biomarker
11.3.8.2.4. By Application
11.3.8.2.5. By End User
12. South America Minimally Invasive Biopsy Techniques Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
12.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
12.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
12.2.4. By Application (Clinical v/s Therapeutic)
12.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
12.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
12.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
12.2.6. By Country
12.3. South America: Country Analysis
12.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Product Offered
12.3.1.2.2. By Technique
12.3.1.2.3. By Circulating Biomarker
12.3.1.2.4. By Application
12.3.1.2.5. By End User
12.3.2. Argentina Minimally Invasive Biopsy Techniques Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Product Offered
12.3.2.2.2. By Technique
12.3.2.2.3. By Circulating Biomarker
12.3.2.2.4. By Application
12.3.2.2.5. By End User
12.3.3. Colombia Minimally Invasive Biopsy Techniques Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Product Offered
12.3.3.2.2. By Technique
12.3.3.2.3. By Circulating Biomarker
12.3.3.2.4. By Application
12.3.3.2.5. By End User
13. Middle East and Africa Minimally Invasive Biopsy Techniques Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
13.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
13.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
13.2.4. By Application (Clinical v/s Therapeutic)
13.2.4.1. By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
13.2.4.2. By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
13.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
13.2.6. By Country
13.3. MEA: Country Analysis
13.3.1. Turkey Minimally Invasive Biopsy Techniques Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Product Offered
13.3.1.2.2. By Technique
13.3.1.2.3. By Circulating Biomarker
13.3.1.2.4. By Application
13.3.1.2.5. By End User
13.3.2. Egypt Minimally Invasive Biopsy Techniques Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Product Offered
13.3.2.2.2. By Technique
13.3.2.2.3. By Circulating Biomarker
13.3.2.2.4. By Application
13.3.2.2.5. By End User
13.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Product Offered
13.3.3.2.2. By Technique
13.3.3.2.3. By Circulating Biomarker
13.3.3.2.4. By Application
13.3.3.2.5. By End User
13.3.4. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
13.3.4.1. Market Size & Forecast
13.3.4.1.1. By Value
13.3.4.2. Market Share & Forecast
13.3.4.2.1. By Product Offered
13.3.4.2.2. By Technique
13.3.4.2.3. By Circulating Biomarker
13.3.4.2.4. By Application
13.3.4.2.5. By End User
13.3.5. UAE Minimally Invasive Biopsy Techniques Market Outlook
13.3.5.1. Market Size & Forecast
13.3.5.1.1. By Value
13.3.5.2. Market Share & Forecast
13.3.5.2.1. By Product Offered
13.3.5.2.2. By Technique
13.3.5.2.3. By Circulating Biomarker
13.3.5.2.4. By Application
13.3.5.2.5. By End User
14. Market Dynamics
14.1. Drivers
14.2. Challenges
15. Market Trends & Developments
16. Competitive Landscape (Inclusive of SWOT Analysis)
16.1. Thermo Fisher Scientific, Inc.
16.2. F. Hoffmann-La Roche AG
16.3. QIAGEN NV
16.4. Guardant Health, Inc.
16.5. Veracyte, Inc.
16.6. Myriad Genetics, Inc.
16.7. Biocept, Inc.
16.8. NeoGenomics Laboratories, Inc.
16.9. Adaptive Biotechnologies Corporation
16.10. DermTech, Inc.
17. Strategic Recommendations
18. About Us & Disclaimer



List of Figures

Figure 1: Global Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 3: Global Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 4: Global Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 5: Global Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 6: Global Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 7: Global Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 8: Global Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 9: Global Minimally Invasive Biopsy Techniques Market Share, By Region, By Value, 2017-2027F
Figure 10: Global Minimally Invasive Biopsy Techniques Market Share, By Company, By Value, 2021
Figure 11: Global Minimally Invasive Biopsy Techniques Market Map, By Product Offered, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Minimally Invasive Biopsy Techniques Market Map, By Technique, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: Global Minimally Invasive Biopsy Techniques Market Map, By Circulating Biomarker Market Size (USD Million) & Growth Rate (%), 2021
Figure 14: Global Minimally Invasive Biopsy Techniques Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 15: Global Minimally Invasive Biopsy Techniques Market Map, By Clinical Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 16: Global Minimally Invasive Biopsy Techniques Market Map, By Therapeutic Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 17: Global Minimally Invasive Biopsy Techniques Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021

Figure 18: Global Minimally Invasive Biopsy Techniques Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021

Figure 19: North America Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 20: North America Minimally Invasive Biopsy Techniques Market Share, By Product, By Value, 2017-2027F
Figure 21: North America Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 22: North America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 23: North America Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 24: North America Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 25: North America Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 26: North America Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 27: North America Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 28: United States Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 29: United States Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 30: United States Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 31: United States Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 32: United States Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F

Figure 33: United States Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 34: Canada Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 35: Canada Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 36: Canada Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 37: Canada Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 38: Canada Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 39: Canada Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 40: Mexico Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 41: Mexico Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 42: Mexico Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 43: Mexico Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 44: Mexico Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 45: Mexico Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 46: Europe Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 47: Europe Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 48: Europe Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 49: Europe Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 50: Europe Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 51: Europe Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 52: Europe Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 53: Europe Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 54: Europe Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 55: Germany Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 56: Germany Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 57: Germany Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 58: Germany Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 59: Germany Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 60: Germany Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 61: France Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 62: France Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 63: France Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 64: France Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 65: France Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 66: France Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 67: United Kingdom Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 68: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 69: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 70: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 71: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 72: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 73: Italy Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 74: Italy Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 75: Italy Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 76: Italy Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 77: Italy Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 78: Italy Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 79: Spain Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 80: Spain Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 81: Spain Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 82: Spain Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 83: Spain Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 84: Spain Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 85: Poland Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 86: Poland Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 87: Poland Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 88: Poland Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 89: Poland Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 90: Poland Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 91: Asia-Pacific Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 92: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 93: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 94: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 95: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 96: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 97: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 98: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 99: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 100: China Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 101: China Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 102: China Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 103: China Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 104: China Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 105: China Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 106: India Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 107: India Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 108: India Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 109: India Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 110: India Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 111: India Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 112: Japan Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 113: Japan Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 114: Japan Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 115: Japan Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 116: Japan Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 117: Japan Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 118: South Korea Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 119: South Korea Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 120: South Korea Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 121: South Korea Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 122: South Korea Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 123: South Korea Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 124: Australia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 125: Australia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 126: Australia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 127: Australia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 128: Australia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 129: Australia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 130: Thailand Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 131: Thailand Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 132: Thailand Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 133: Thailand Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 134: Thailand Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 135: Thailand Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 136: Vietnam Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 137: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 138: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 139: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 140: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 141: Vietnam Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 142: Malaysia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 143: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 144: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 145: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 146: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 147: Malaysia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 148: South America Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 149: South America Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 150: South America Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 151: South America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 152: South America Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 153: South America Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 154: South America Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 155: South America Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 156: South America Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 157: Brazil Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 158: Brazil Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 159: Brazil Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 160: Brazil Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 161: Brazil Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 162: Brazil Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 163: Argentina Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 164: Argentina Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 165: Argentina Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 166: Argentina Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 167: Argentina Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 168: Argentina Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 169: Colombia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 170: Colombia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 171: Colombia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 172: Colombia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 173: Colombia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 174: Colombia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 175: Middle East and Africa Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 176: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 177: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 178: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 179: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 180: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 181: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 182: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 183: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 184: Turkey Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 185: Turkey Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 186: Turkey Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 187: Turkey Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 188: Turkey Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 189: Turkey Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 190: Egypt Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 191: Egypt Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 192: Egypt Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 193: Egypt Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 194: Egypt Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 195: Egypt Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 196: South Africa Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 197: South Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 198: South Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 199: South Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 200: South Africa Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 201: South Africa Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 202: Saudi Arabia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 203: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 204: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 205: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 206: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 207: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 208: UAE Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 209: UAE Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 210: UAE Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 211: UAE Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 212: UAE Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 213: UAE Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F